Lake Mary, Florida (PRWEB) December 18, 2014
Axium Healthcare Pharmacy announced today that it is now a participating specialty pharmacy in the Pfizer Limited Distribution Oncology Network. Axium, as a member of the network, is authorized to dispense and support Pfizer’s specialty oral oncology drugs including Sutent®, Inlyta®, Bosulif® and Xalkori®.
“For years, Axium Healthcare Pharmacy has provided oncology patients, providers and partners with the necessary coordination of care vital to achieving successful treatment outcomes through our OncologyVisions® therapy management program,” says, Mark Montgomery, President and CEO of Axium Healthcare. “Axium is able to offer high-quality, personalized care, ongoing patient evaluation and clinical support including frequent patient follow-up and continual education about their oncology treatments. Axium believes that in doing this, we can guide patients and partners along a better path to oncology care.”
Learn more about Axium Healthcare Pharmacy’s OncologyVisions® program at axiumhealthcare.com/oncology.
--About Axium Healthcare Pharmacy--
Founded in 2000, Axium Healthcare Pharmacy, Inc. is a nationwide provider of specialty pharmacy services. A wholly-owned subsidiary of The Kroger Company, Axium provides drug therapies and patient support services to treat chronic, genetic, and other complex conditions such as Hepatitis C, Multiple Sclerosis, Cancer, Rheumatoid Arthritis, and a number of others.
For more information, contact Axium Healthcare Pharmacy at 888.315.3395 or visit http://www.axiumhealthcare.com.